MGNX - Macrogenics Inc
IEX Last Trade
3.52
0.050 1.420%
Share volume: 1,276,805
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.47
0.05
1.44%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-08 | 2022-11-03 | 2023-03-15 | 2023-05-09 | 2023-08-09 | 2023-11-06 | 2024-03-07 | 2024-05-09 | |
Total revenue | 26.007 M | 41.734 M | 73.099 M | 24.496 M | 13.136 M | 10.397 M | 10.720 M | 9.104 M | |
Cost of revenue | 2.402 M | 3.143 M | 1.791 M | 3.523 M | 1.177 M | 3.359 M | 163.000 K | 2.116 M | |
Gross profit | 23.605 M | 38.591 M | 71.308 M | 20.973 M | 11.959 M | 7.038 M | 10.557 M | 6.988 M | |
63.49% | 84.78% | -70.59% | -42.98% | -41.15% | 50.00% | -33.81% | |||
Operating expenses | 65.413 M | 63.546 M | 59.325 M | 59.399 M | 56.921 M | 42.540 M | 59.911 M | 60.738 M | |
Selling general and admin | 13.669 M | 15.355 M | 13.672 M | 13.527 M | 13.692 M | 12.409 M | 12.560 M | 14.709 M | |
Research and development | 51.744 M | 48.191 M | 45.653 M | 45.872 M | 43.229 M | 30.131 M | 47.351 M | 46.029 M | |
Total expenses | 67.815 M | 66.689 M | 61.116 M | 62.922 M | 58.098 M | 45.899 M | 60.074 M | 62.854 M | |
-1.66% | -8.36% | 2.96% | -7.67% | -21.00% | 30.88% | 4.63% | |||
Operating income | -41.808 M | -24.955 M | 11.983 M | -38.426 M | -44.962 M | -35.502 M | -49.354 M | -53.750 M | |
Ebit | -41.808 M | -24.955 M | 11.983 M | -38.426 M | -44.962 M | -35.502 M | -49.354 M | -53.750 M | |
Pretax income | -41.304 M | -24.813 M | 12.802 M | -38.009 M | 57.469 M | 17.554 M | -46.072 M | -52.190 M | |
-39.93% | -151.59% | -396.90% | -251.20% | -69.45% | -362.46% | 13.28% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -41.304 M | -24.813 M | 12.802 M | -38.009 M | 57.469 M | 17.554 M | -46.072 M | -52.190 M | |
39.93% | 151.59% | -396.90% | 251.20% | -69.45% | -362.46% | -13.28% | |||
Net income | -41.304 M | -24.813 M | 12.802 M | -38.009 M | 57.469 M | 17.554 M | -46.072 M | -52.190 M | |
39.93% | 151.59% | -396.90% | 251.20% | -69.45% | -362.46% | -13.28% |